Unstable Angina & NSTEMI

Live Streams

Improving Care Decisions After Coronary Revascularisation Satellite Symposium At The ESC Congress 2017

The following symposia is intended for physicians based in specific regions only - by accepting this invite you are confirming that you are a physician based in one of the following regions. Please select your location from the below:

Practical Applications for Single Pill Combinations in the Cardiovascular Continuum

Cardiovascular disease (CVD) is the leading cause of death worldwide and it is predicted that its incidence will increase markedly, particularly in developed countries, despite the introduction of new drugs and devices. One of the factors accounting for the limited effectiveness of pharmacological therapy is poor adherence to treatment, particularly in elderly patients. The use of combinations of multiple agents in a single pill formulation could be of value in improving adherence to treatment and disease control, as well as conferring other favourable actions.

Women with Stable Angina Pectoris and No Obstructive Coronary Artery Disease: Closer to a Diagnosis

Women have for many years been regarded as being at relatively low risk for the development of ischaemic heart disease (IHD).1,2 Recently this pattern has changed and cardiovascular disease (CVD) is now the leading cause of death for women in Europe.3,4 Under the age of 60 years acute coronary syndrome occurs 3–4 times more often in men; however, after the age of 75 years women represent the majority of the patients.

Cardiovascular Disease in Women: Understanding Symptoms and Risk Factors

Globally, cardiovascular disease (CVD) remains the leading cause of mortality in women. Approximately 2.8 million women have been diagnosed with CVD in the UK.1 For many years, the presence of gender-related differences in presentation, risk factors and outcomes have been recognised. Importantly, these discrepancies in presentation and outcomes between the sexes are often associated with inequalities in the detection, referral and management of CVD.